BioStock: DanCann's CEO on the intensive news flow

The use of medical cannabis has strong tailwinds in much of the world, not only in terms of medical acceptance, but also because it is based on frontline research and is a flourishing business. In Denmark, one of the most high-profile players in the field is biotech DanCann Pharma; despite having been being a listed company for only a few months, it has already established several collaborations. The last weeks has been particularly intensive for DanCann Pharma, and BioStock turned to CEO and founder Jeppe Krog Rasmussen to find out more about the latest news flow. 

Read the full interview with Jeppe Krog Rasmussen at biostock.se:

https://www.biostock.se/en/dancanns-ceo-on-the-intensive-news-flow/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/